Prognostic Value of Metabolic Dysfunction–Associated Steatotic Liver Disease Based on Body Weight Phenotypes Following Acute Myocardial Infarction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-term all-cause mortality of metabolic-dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study
Diabetes Obes Metab 2024 Nov 11;[EPub Ahead of Print], J Koh, A Mohamed, G Kong, E Wong, Y Chen, VV Anand, B Chong, YH Chin, JW Wang, CM Khoo, SP Chan, M Muthiah, GK Dimitriadis, MY Chan, PH Loh, NWS ChewFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.